Literature DB >> 13032434

Clinical trial of phenylindanedione as an anticoagulant.

M TOOHEY.   

Abstract

Entities:  

Keywords:  PHENYLINDANEDIONE/therapeutic use; THROMBOSIS/therapy

Mesh:

Substances:

Year:  1953        PMID: 13032434      PMCID: PMC2015732          DOI: 10.1136/bmj.1.4811.650

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1952-09-27

2.  The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.

Authors:  C J BJERKELUND
Journal:  Scand J Clin Lab Invest       Date:  1950       Impact factor: 1.713

3.  Preliminary report on the clinical use of a new anticoagulant, phenylindandione.

Authors:  A U BLAUSTEIN; J J CROCE; M ALBERIAN; N RICHEY
Journal:  Circulation       Date:  1950-05       Impact factor: 29.690

  3 in total
  13 in total

1.  FATAL MYOCARDITIS DUE TO SENSITIVITY TO PHENINDIONE.

Authors:  A J KERWIN
Journal:  Can Med Assoc J       Date:  1964-06-20       Impact factor: 8.262

2.  Side-effect of phenindione.

Authors:  J B ROSS
Journal:  Br Med J       Date:  1963-03-30

3.  Hepatitis due to phenindione sensitivity.

Authors:  N L JONES
Journal:  Br Med J       Date:  1960-08-13

4.  Clinical evaluation of three anticoagulants in thrombo-embolic disease.

Authors:  J M NEILSON; A W MOLLISON
Journal:  Br Med J       Date:  1957-05-25

5.  Haemorrhage during phenindione therapy.

Authors:  J N MICKERSON
Journal:  Br Med J       Date:  1958-06-28

6.  Phenylpropyl-hydroxycoumarin as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1956-01-07

7.  Cardiac emergencies.

Authors:  D WHEATLEY
Journal:  Proc R Soc Med       Date:  1954-05

8.  Phenylindanedione: a useful anticoagulant.

Authors:  S R TOWNSEND; K J FAY; J R DOWNING; R LAING; D G CAMERON
Journal:  Can Med Assoc J       Date:  1953-08       Impact factor: 8.262

9.  The mode of action of phenylindanedione.

Authors:  W WALKER; R B HUNTER
Journal:  J Clin Pathol       Date:  1954-08       Impact factor: 3.411

10.  Factors affecting warfarin requirements. A prospective population study.

Authors:  P A Routledge; P H Chapman; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.